Friday, January 30, 2026
19.8 C
Bengaluru

The Evolving Role of HR in Pharma: Why Non-Pharma Backgrounds are Raising the Game

The pharmaceutical sector—high-stakes, heavily regulated, and innovation-driven—has historically preferred HR leaders with sector-specific experience. Yet, the landscape is changing rapidly. With new challenges such as digital transformation, DEI (Diversity, Equity, Inclusion), talent management, and global expansion, fresh perspectives from HR professionals outside the pharma world are proving to be a strategic advantage.

Why HR is Central to Pharma’s Success: Key Pillars

Compliance & Governance:

The need for regulatory compliance in pharma is non-negotiable. HR ensures employees are accurately trained, policies are adhered to, and swift action is taken on breaches. This limits legal risks and protects the company’s reputation.​

Talent Management:

Attracting and retaining multidisciplinary talent is crucial as pharma moves beyond chemistry to data science, digital health, and global supply chains. HR is pivotal in broadening the recruitment funnel and supporting upskilling and internal mobility.​

Driving Innovation & Agility:

Pharma faces fast-changing science, regulations, and patient needs. HR develops cultures of continuous learning, collaboration, and change-readiness—factors now seen as vital for rapid innovation and adaptation.​

Diversity & Inclusion:

In a global marketplace, understanding diverse patient and customer segments is paramount. Pharma HR now leads DEI efforts, aiming for inclusive hiring and employee experience practices—areas where outside-industry HR leaders often bring proven frameworks.​

Employee Well-being & Experience:

Burnout and stress are acute in healthcare. HR’s proactive investment in employee wellness, mental health, and flexible/hybrid models draws from practices in IT, BFSI, and FMCG, and is raising pharma’s employer value proposition.​

How HR Professionals from Non-Pharma Backgrounds Make an Impact

1.⁠ ⁠New Approaches to Digital and People Analytics

Example: An HR leader from IT—hired by a top Indian pharma MNC—introduced analytics-led hiring and retention practices, reducing attrition by 17% and improving workforce planning accuracy.​

2.⁠ ⁠Leading Culture & Change Management During M&A

Example: A manufacturing sector HR head successfully led post-merger integration at a global pharma organization, leveraging prior experience with cultural due diligence, resulting in higher employee engagement scores vs. sector average.​

3.⁠ ⁠Bringing Agility from FMCG/Consumer Sectors

Example: HR leaders from FMCG have driven flexible working, rapid onboarding, and ‘internal gig’ programs in pharma, enhancing speed of product launches and cross-functional project success rates.​

4.⁠ ⁠Diversity-Driven Strategies from Banking/Services

Example: Pharma companies have benefited from CHROs previously in BFSI, who introduced targeted leadership pipelines for women, leading to double-digit increases in senior female representation.​

Spotlight:

Granules India and Vinodkumar Parur’s Strategic Role as CHRO

Granules India is a leading pharmaceutical company specializing in active pharmaceutical ingredients (APIs), pharmaceutical formulations, and drug products across regulated and emerging markets. With a robust presence in India and globally, the company drives growth through innovation, global expansion, and operational excellence.

Appointing Vinodkumar Parur as CHRO effective November 17, 2025, reflects Granules India’s strategy to strengthen its human capital leadership amid the complex pharma environment. Parur brings over 24 years of HR leadership across manufacturing, engineering, infrastructure, and pharma sectors. His expertise in HR transformation, IPOs, mergers, talent management, and digital HR initiatives positions him well to:

Navigate pharma’s regulatory and compliance complexities.

Foster a culture of agility and innovation in a fast-evolving industry.

Lead recruitment and retention of specialized talent crucial to R&D and global expansion.

Champion employee engagement and leadership development to boost organizational performance.

This leadership move underscores the importance of diverse sector experience in driving HR excellence in pharma.​

Critical Reflection:

Sector Expertise vs. Strategic Perspective

Advantages of Non-Pharma HR: They disrupt organizational inertia, catalyze innovation, and adopt best-in-class practices (digital, DEI, analytics) proven in other sectors.

Possible Gaps: Pharma’s regulatory and compliance demands require strong onboarding and collaboration with in-house scientific teams.​

Bottom Line:

Pharma HR needs a blend of insider expertise and outsider innovation. As the sector diversifies and globalizes, HR leaders from varied industries are essential for future-proofing pharma organizations.

Appendix: Sources

Pharma Now Live – The Changing Roles Of HR In The Pharma Industry

https://www.pharmanow.live/hr-in-pharma/changing-hr-roles-pharmaceutical-industry​

ISBR – Role of HR in Pharma Industry and Recruitment Challenges

https://www.isbr.in/blogs/role-of-hr-in-pharma-industry-and-recruitment-challenges/​

Hppy – HR Evolution in Pharmaceutical & Biotech Sectors 2025

https://www.hppy.com/hr-evolution-in-pharmaceutical-and-biotech-sectors-for-2025​

Key Consulting Group – Navigating HR in Pharma: Unique challenges, strategies, and insights

https://www.keyconsulting-group.com/2024/10/15/navigating-hr-in-pharma-unique-challenges-strategies-and-insights/​

PharmExec – A New Game Plan for Pharma HR

https://www.pharmexec.com/view/new-game-plan-pharma-hr​

IRJEMS – Best Human Resource Practices in the Indian Pharmaceutical Industry

https://irjems.org/Volume-3-Issue-10/IRJEMS-V3I10P119.pdf​

Pharma Now Live – HR Best Practices for Pharma Mergers & Acquisitions

https://www.pharmanow.live/hr-in-pharma/hr-best-practices-mergers-challenges​

People Matters – Granules India appoints Vinodkumar Parur as new CHRO

https://www.peoplematters.in/news/appointments/granules-india-appoints-vinodkumar-parur-as-new-chro-47233​

All Images are AI Generated for Illustration Only. E&OE

Hot this week

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Topics

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...
spot_img

Related Articles

spot_imgspot_img